Sathy V. Balu-Iyer
Affiliations: | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
General Biophysics, PharmacyGoogle:
"Sathy Balu-Iyer"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Razvan D. Miclea | grad student | 2007 | SUNY Buffalo |
| Aaron Peng | grad student | 2011 | SUNY Buffalo |
| Puneet R. Gaitonde | grad student | 2012 | SUNY Buffalo |
| Dipak S. Pisal | grad student | 2012 | SUNY Buffalo |
| Matthew P. Kosloski | grad student | 2013 | SUNY Buffalo |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jarvi NL, Balu-Iyer SV. (2021) Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy |
| Dingman R, Balu-Iyer SV. (2018) Immunogenicity of Protein Pharmaceuticals. Journal of Pharmaceutical Sciences |
| Shenoy GN, Loyall J, Berenson CS, et al. (2018) Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments. Journal of Immunology (Baltimore, Md. : 1950) |
| Glassman FY, Balu-Iyer SV. (2018) Subcutaneous Administration of Lyso-Phosphatidylserine Nanoparticles Induces Immunological Tolerance Towards Factor VIII in a Hemophilia A Mouse Model. International Journal of Pharmaceutics |
| Glassman FY, Schneider JL, Ramakrishnan R, et al. (2018) Phosphatidylserine is not just a cleanup crew but also a well-meaning teacher. Journal of Pharmaceutical Sciences |
| Turner MR, Balu-Iyer SV. (2018) Challenges and opportunities for the subcutaneous delivery of therapeutic proteins. Journal of Pharmaceutical Sciences |
| Schneider JL, Dingman RK, Balu-Iyer SV. (2017) Lipidic Nanoparticles Comprising of Phosphatidylinositol Mitigate Immunogenicity and Improve Efficacy of Recombinant Human Acid Alpha-Glucosidase in a Murine Model of Pompe Disease. Journal of Pharmaceutical Sciences |
| Schneider JL, Balu-Iyer SV. (2016) Phosphatidylserine Converts Immunogenic Recombinant Human Acid Alpha-Glucosidase to a Tolerogenic Form in a Mouse Model of Pompe Disease. Journal of Pharmaceutical Sciences |
| Ramakrishnan R, Balu-Iyer SV. (2016) Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model. Journal of Pharmaceutical Sciences |
| Shetty KA, Kosloski MP, Mager DE, et al. (2016) Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-Factor VIII antibodies in Hemophilia A mice. Biopharmaceutics & Drug Disposition |